Final results of a multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with metastatic gastric or gastroesophageal (GEJ) adenocarcinoma (NCI #6447) Meeting Abstract


Authors: Shah, M. A.; Ramanathan, R. K.; Ilson, D.; Randazzo, J.; Schwartz, G. K.; Tse, A.; D'adamo, D.; Levner, A.; Capanu, M.; Kelsen, D. P.
Abstract Title: Final results of a multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with metastatic gastric or gastroesophageal (GEJ) adenocarcinoma (NCI #6447)
Meeting Title: 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 24
Issue: 18 Suppl. Pt. 1
Meeting Dates: 2006 Jun 2-6
Meeting Location: Atlanta, GA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2006-06-01
Start Page: 183S
Language: English
ACCESSION: WOS:000239009401167
PROVIDER: wos
Notes: --- - Meeting Abstract: 4020 - 42nd Annual Meeting of the American-Society-of-Clinical-Oncology - JUN 02-06, 2006 - Atlanta, GA - "Source: Wos"
MSK Authors
  1. Gary Schwartz
    364 Schwartz
  2. David R D'Adamo
    37 D'Adamo
  3. Archie Tse
    34 Tse
  4. Marinela Capanu
    211 Capanu
  5. Manish Shah
    175 Shah
  6. David H Ilson
    275 Ilson
  7. David P Kelsen
    341 Kelsen
  8. Jennifer L Russo
    10 Russo